Amended Statement of Ownership (sc 13g/a)
15 February 2022 - 3:14AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
Amendment #1
Kindred
Biosciences, Inc
(Name of Issuer)
Common Stock
(Title of
Class of Securities)
494577109
(CUSIP Number)
December
31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
This Schedule is filed pursuant to Rule 13d-1(b)
The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be
filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
CUSIP NO. 494577109
|
|
|
|
|
|
|
1)
|
|
Name of Reporting
Person Ameriprise Financial, Inc.
S.S. or I.R.S.
Identification IRS No. 13-3180631
No. of Above Person
|
2)
|
|
Check the Appropriate Box
if a Member of a Group
(a) ☐ (b) ☒*
* This filing describes the
reporting persons relationship with other persons, but the reporting person does not affirm the existence of a group.
|
3)
|
|
SEC Use Only
|
4)
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5)
|
|
Sole Voting Power
0
|
|
6)
|
|
Shared Voting Power
0
|
|
7)
|
|
Sole Dispositive Power
0
|
|
8)
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
9)
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10)
|
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares
Not
Applicable
|
11)
|
|
Percent of Class
Represented by Amount In Row (9)
0.00%
|
12)
|
|
Type of Reporting
Person
HC
|
CUSIP NO. 494577109
|
|
|
|
|
|
|
1)
|
|
Name of Reporting
Person Columbia Management
Investment
Advisers, LLC
S.S. or I.R.S.
Identification IRS No. 41-1533211
No. of Above Person
|
2)
|
|
Check the Appropriate Box
if a Member of a Group
(a) ☐ (b) ☒*
* This filing describes the
reporting persons relationship with other persons, but the reporting person does not affirm the existence of a group.
|
3)
|
|
SEC Use Only
|
4)
|
|
Citizenship or Place of
Organization
Minnesota
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5)
|
|
Sole Voting Power
0
|
|
6)
|
|
Shared Voting Power
0
|
|
7)
|
|
Sole Dispositive Power
0
|
|
8)
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
9)
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10)
|
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares
Not
Applicable
|
11)
|
|
Percent of Class
Represented by Amount In Row (9)
0.00%
|
12)
|
|
Type of Reporting
Person
IA
|
|
|
|
|
|
1(a)
|
|
Name of Issuer:
|
|
Kindred Biosciences, Inc
|
|
|
|
1(b)
|
|
Address of Issuers Principal
|
|
1555 Bayshore Highway, Suite 200
|
|
|
Executive Offices:
|
|
Burlingame, California 9401
|
|
|
|
2(a)
|
|
Name of Person Filing:
|
|
(a) Ameriprise Financial, Inc. (AFI)
|
|
|
|
|
(b) Columbia Management Investment
Advisers, LLC (CMIA)
|
|
|
|
2(b)
|
|
Address of Principal Business Office:
|
|
(a) Ameriprise Financial, Inc.
|
|
|
|
|
145 Ameriprise Financial Center
|
|
|
|
|
Minneapolis, MN 55474
|
|
|
|
|
(b) 290 Congress St.
|
|
|
|
|
Boston, MA 02210
|
|
|
|
2(c)
|
|
Citizenship:
|
|
(a) Delaware
(b)
Minnesota
|
|
|
|
2(d)
|
|
Title of Class of Securities:
|
|
Common Stock
|
|
|
|
2(e)
|
|
Cusip Number:
|
|
494577109
|
3
|
Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):
|
(a) Ameriprise Financial, Inc.
A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
(b) Columbia Management Investment Advisers, LLC
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
4
|
Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.
|
AFI, as the parent company of CMIA, may be deemed to beneficially own the shares reported herein by CMIA. Accordingly,
the shares reported herein by AFI include those shares separately reported herein by CMIA.
Each of AFI and CMIA disclaims beneficial
ownership of any shares reported on this Schedule.
5
|
Ownership of 5% or Less of a Class:
|
If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following (X).
6
|
Ownership of more than 5% on Behalf of Another Person: Not Applicable
|
7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent
Holding Company:
|
AFI: See Exhibit I
8
|
Identification and Classification of Members of the Group:
|
Not Applicable
9
|
Notice of Dissolution of Group:
|
Not Applicable
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such
purposes or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 14, 2022
|
|
|
Ameriprise Financial, Inc.
|
|
|
By:
|
|
/s/ Michael G. Clarke
|
Name:
|
|
Michael G. Clarke
|
Title:
|
|
Senior Vice President, Head of Global Operations
|
|
Columbia Management Investment Advisers, LLC
|
|
|
By:
|
|
/s/ Michael G. Clarke
|
Name:
|
|
Michael G. Clarke
|
Title:
|
|
Senior Vice President, Head of Global Operations
|
|
Contact Information
Mark D. Braley
Vice President
Head of Reporting and Data Management Global Operations and Investor Services
Telephone: (617) 747-0663
|
Exhibit Index
|
|
|
Exhibit I
|
|
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.
|
|
|
Exhibit II
|
|
Joint Filing Agreement
|
Kindred Biosciences (NASDAQ:KIN)
Historical Stock Chart
From Apr 2024 to May 2024
Kindred Biosciences (NASDAQ:KIN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Kindred Biosciences Inc (NASDAQ): 0 recent articles
More Kindred Biosciences, Inc. News Articles